(Q52243536)

27 April 2018

title

A cost-benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example. (English)

1 reference

27 April 2018

main subject

cardiovascular disease

1 reference

inferred from title

cost–benefit analysis

1 reference

1 reference

1 reference

Hornberger J

1

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

27 April 2018

American Journal of Public Health

published in

1 reference

27 April 2018

volume

88

1 reference

27 April 2018

issue

1

1 reference

27 April 2018

page(s)

61-67

1 reference

27 April 2018

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Homocysteine and coronary atherosclerosis

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Fortification of the food supply with folic acid to prevent neural tube defects is not yet warranted

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Designing a cost-effective clinical trial.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

The hemodialysis prescription and cost effectiveness. Renal Physicians Association Working Committee on Clinical Guidelines

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

A case for Bayesianism in clinical trials

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

A sample-size-optimal Bayesian procedure for sequential pharmaceutical trials

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Decision-analytic determination of study size. The case of electronic fetal monitoring

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

A bayesian approach to the design of phase II clinical trials.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Time preference for health in cost-effectiveness analysis

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Statistical analysis of quality of life data in cancer clinical trials

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508371

Are clinical trials a cost-effective investment?

7 September 2018

1 reference

12 December 2020

Expected gains in life expectancy from various coronary heart disease risk factor modifications

1 reference

12 December 2020

Treatment of mild hyperhomocysteinemia in vascular disease patients

1 reference

12 December 2020

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

12 December 2020

Can Lowering Homocysteine Levels Reduce Cardiovascular Risk?

1 reference

12 December 2020

Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid

1 reference

12 December 2020

Folate levels and neural tube defects. Implications for prevention

1 reference

12 December 2020

Cost-effective priorities for cancer prevention

1 reference

12 December 2020

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

12 December 2020

Identifiers

DOI

10.2105/AJPH.88.1.61

1 reference

27 April 2018

PMC publication ID

1508371

0 references

1 reference

27 April 2018